GlassScriptPhysician profile
Amir Abdoly
NPI 1861938383
$8,317.00
in general payments reported to CMS, 2019-2025
36 companies · $1,122 in 2025
The $1,122 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $179 · 2021: $133 · 2022: $2,475 · 2023: $1,240 · 2024: $2,935 · 2025: $1,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,297.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,889.22 | 2022-2025 | Impella |
| Medtronic, INC. | $1,787.67 | 2021-2025 | Linq II, Abre, Hawkone |
| Cms Imaging, INC. | $456.22 | 2022 | |
| Janssen Pharmaceuticals, INC | $325.85 | 2022-2023 | Xarelto |
| Abbott Laboratories | $314.11 | 2020-2024 | Amplatzer Talisman, Coroflow, Gallant |
| Canon Medical Systems USA, INC. | $273.20 | 2022 | |
| Shockwave Medical, INC | $265.71 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $262.08 | 2020-2025 | |
| Pfizer INC. | $257.50 | 2021-2025 | |
| Boston Scientific Corporation | $248.80 | 2023-2024 | Hornet 10, Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $237.22 | 2019-2024 | Farxiga |
| Bard Peripheral Vascular, INC. | $233.78 | 2024 | Venclose Maven Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $184.40 | 2022-2024 | Jardiance |
| Novo Nordisk INC | $158.62 | 2024-2025 | Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $150.09 | 2022-2025 | Camzyos, Eliquis |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $134.80 | 2021-2025 | Repatha, Repatha |
| Penumbra, INC. | $134.32 | 2024 | Indigo System |
| Abbvie INC. | $124.99 | 2019 | |
| Cvrx, INC. | $112.34 | 2023-2025 | Barostim Neo System |
| Angiodynamics, INC. | $108.05 | 2023-2025 | Auryon Laser System 100-120 Vac |
| Avinger INC. | $106.80 | 2022 | |
| Philips North America LLC | $93.26 | 2024 | (Br5) Peripheral Ivus, (Ck7) Extended Holter |
| Kiniksa Pharmaceuticals International, Plc | $79.65 | 2024 | Arcalyst |
| Merck Sharp & Dohme LLC | $74.35 | 2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $67.15 | 2024-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $57.83 | 2022 | |
| Cardiovascular Systems INC. | $22.97 | 2022 | |
| Sanofi-Aventis U.S. LLC | $22.22 | 2023 | |
| Cardinal Health 200 LLC | $20.60 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $19.38 | 2023 | Inpefa |
| Alnylam Pharmaceuticals INC. | $19.20 | 2025 | Amvuttra |
| Cardiva Medical, INC. | $16.73 | 2022 | |
| Irhythm Technologies, INC. | $14.80 | 2024 | Zio Monitor, Zio Xt Patch |
| Terumo Medical Corporation | $14.72 | 2025 | Angio-Seal |
| Bayer Healthcare Pharmaceuticals INC. | $14.53 | 2025 | |
| Esperion Therapeutics, INC. | $13.84 | 2025 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Abdoly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.